Gossamer Bio, Inc. (GOSS)

2.26 -0.18 (-7.19%) USD  |  NASDAQ  |  Feb 06, 16:00
2.29 +0.03 (+1.33%) After-Hours: 20:00
More

Gossamer Bio SG&A Expense (TTM) : 36.12M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. 715.08M
XOMA Royalty Corp. 32.68M
Rezolute, Inc. 20.85M
Axsome Therapeutics, Inc. 514.57M
Crinetics Pharmaceuticals, Inc. 165.81M